Floatz logo

RETEPLASE, RECOMBINANT

Alteplase

Changhai Hospitalprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Alteplase cohort.

Asset / SponsorPhaseRating
Prourokinase
Changhai Hospital
N/AD

Same molecule, other indications

RETEPLASE, RECOMBINANT is also rated in:

Acute Ischemic StrokeDormant
B
Indicative ·
63 / 100
View asset →
Basilar Artery OcclusionDormant
B
Indicative ·
60 / 100
View asset →
stroke disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →